Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Best ETFs for 2019: Capitalize on Mexico’s Strength With the EWW ETF

Media headlines make Mexico seem really scary right now, but it's fundamentals are strong, and the new NAFTA deal should help EWW in 2019.

Why Aurora Cannabis Stock Will Drop Back Under $5

Aurora's recent Mexico deal is unlikely to deliver huge results anytime soon. That could be a problem as ACB stock has run up to a truly massive valuation.

Verizon Stock Shows Its Mettle Is Solid In This Shaky Market

Verizon offers a safe, high yield, and has shown impressive resilience during this market sell-off. Here are the factors driving VZ stock's outperformance.

Why I’m Not Buying the Bull Case For Disney Stock

Disney stock is only a buy if it can break out of its current technical resistance point. Otherwise, fundamental factors are likely to keep the stock pinned down.

What Cronos Stock Investors Should Do After the Altria Buyout

Altria has changed the game for Cronos shareholders. Here's how investors should trade CRON stock going forward.

Microsoft Overtakes Apple, Eyes Trillion Dollar Market Cap in 2019

MSFT stock recently overtook Apple for the top spot as the world's largest company -- for good reason. Here's how and why it happened.

There’s No Way You Should Be Paying These Prices for SBUX Stock

SBUX stock just hit new all-time highs. But don't expect more holiday cheer. Here's why you should ring the register now.

The Trade War Could Be a Positive Catalyst for Cara Therapeutics Stock

Growing pressure to take action against China's illicit drug production could make investors more interested in CARA stock, potentially causing Cara Therapeutics stock to rally.

Apple Stock Won’t Make You Much Money over the Next Few Years

Apple stock is looking a lot closer to fairly priced with the recent correction in its share price. Here's how its upside looks now.

Can Electronic Arts Stock Bounce Back?

Is the pain for EA stock finally coming to an end? After a 40% tumble, here's what lies ahead for Electronic Arts stock.